| 2021-05-03 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 459 | $218.83 | $100,442.97 | -1.3% | → |
| 2021-04-27 | Sachdev Amit | EVP, Chief Patient Officer | Sale+OE | 3,884 | $216.06 | $839,193.14 | -3.1% | → |
| 2021-04-05 | Sanna Bastiano | EVP, Cell & Genetic Therapies | Sell | 1,686 | $214.14 | $361,046.44 | -2.3% | → |
| 2021-03-05 | Liu Joy | SVP, General Counsel | Sell | 5,141 | $209.69 | $1,078,017.59 | -7.8% | → |
| 2021-03-01 | Silva Paul M | SVP & Chief Accounting Officer | Sell | 2,782 | $211.45 | $588,255.25 | -6.1% | → |
| 2021-02-25 | Silva Paul M | SVP & Chief Accounting Officer | Sell | 1,080 | $213.47 | $230,551.50 | -1.7% | → |
| 2021-02-25 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 3,634 | $213.54 | $775,988.98 | -1.4% | → |
| 2021-02-25 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 3,028 | $213.39 | $646,138.52 | -2.1% | → |
| 2021-02-25 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 3,586 | $213.42 | $765,307.40 | -1.7% | → |
| 2021-02-25 | Parini Michael | EVP, Chief Adm, Leg & BD Off | Sell | 3,028 | $213.38 | $646,125.04 | -2.3% | → |
| 2021-02-18 | Sachdev Amit | EVP, Chief Patient Officer | Sell | 8,464 | $211.71 | $1,791,950.00 | -5.2% | → |
| 2021-02-18 | Silva Paul M | SVP & Chief Accounting Officer | Sell | 4,295 | $211.83 | $909,827.62 | -7.2% | → |
| 2021-02-18 | ALTSHULER DAVID | EVP, Global Research and CSO | Sell | 200 | $213.26 | $42,652.00 | -0.5% | → |
| 2021-02-18 | Arbuckle Stuart A | EVP, Chief Commercial Officer | Sell | 6,803 | $212.08 | $1,442,809.67 | -4.5% | → |
| 2021-02-18 | Parini Michael | EVP, Chief Adm, Leg & BD Off | Sell | 200 | $213.45 | $42,690.00 | -0.5% | → |